Clinical Trials Browser

Phase 4 × Irinotecan × 1 year × Clear all

NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4 Suspended

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT07094893 2026-01-14

ARIEL-ENGIC

Phase 4 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms